GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » Change In Other Working Capital

BioNote (XKRX:377740) Change In Other Working Capital : ₩-1,147 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BioNote Change In Other Working Capital?

BioNote's Change In Other Working Capital for the quarter that ended in Dec. 2024 was ₩365 Mil. It means BioNote's Other Working Capital increased by ₩365 Mil from Sep. 2024 to Dec. 2024 .

BioNote's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was ₩-1,147 Mil. It means BioNote's Other Working Capital declined by ₩1,147 Mil from Dec. 2023 to Dec. 2024 .

BioNote Change In Other Working Capital Historical Data

The historical data trend for BioNote's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNote Change In Other Working Capital Chart

BioNote Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial 39,361.27 -23,925.15 -10,295.26 -4,528.70 -1,147.47

BioNote Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,485.29 -1,795.60 1,321.15 -1,037.62 364.60

BioNote Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,147 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNote Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of BioNote's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNote Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » Change In Other Working Capital
Comparable Companies
XKRX:335890 XKRX:290650 XKRX:099190 XKRX:445680 XKRX:206640 XKRX:340570 XKRX:060280 XKRX:450950 XKRX:043150 XKRX:041830 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
22, Samsung 1-ro 4-gil, Gyeonggi-do, Hwaseong-si, KOR
Website
https://www.bionote.co.kr
BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.

BioNote Headlines

No Headlines